The perpetrator potential of sitaxentan: human CYP enzyme induction Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
The perpetrator potential of sitaxentan based on its ability to inhibit human cytochrome P450 (CYP) enzymes Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Source: Eur Respir J 2001; 18: 122S-126S Year: 2001
Absence of inhibitory effect of levocetirizine on the metabolism of human cytochrome P450 model substrates Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
Cytochrome P450 pharmacogenetics: a possible predictor of pulmonary drug induced toxicity? Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007
Interactions between roflumilast and cytochrome P450 inducers and inhibitors: Overview of existing studies Source: Annual Congress 2010 - Management of airway disease Year: 2010
Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge Source: Eur Respir J 2010; 36: 1088-1098 Year: 2010
Association analysis between polymorphisms in the cytochrome P450 2J2, 2S1 and UDP-glucuronosyltransferase 2B7 genes with occupational chronic bronchitis Source: Annual Congress 2010 - Genetics of obstruction Year: 2010
Polymorphisms of genes involved in extracellular matrix remodeling, xenobiotic metabolism, antioxidant pathways and chronic lung disease in children Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012
Effect of ambrisentan, bosentan and macitentan on human hepatic uptake and efflux transporters Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
Comparison of inhibitory potentials of pranlukast and zafirlukast on human liver CYP isoforms Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
Cytochrome P450 2A5 methylation and gene expression profile is organ-specific and affected by maternal smoking during pregnancy Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Cytochrome CYP2C9 and vitamin K epoxide reductase gene polymorphisms in patients with pulmonary embolism treated with warfarin Source: Annual Congress 2007 - The role of gene polymorphisms in pulmonary disease susceptibility Year: 2007
Effects of aryl hydrocarbon receptor and cytochrome P450 1A1 polymorphisms on childhood lung function and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007
Genetic polymorphisms in the cytochromes P450, microsomal epoxide hydrolase and glutathione S-transferase M1, T1 and P1 genes and their relationship to relapsing bronchitis and pneumonia in case of children Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
The effect of antioxidant tetrapeptide UPF1 on enzymes involved in glutathione metabolism in human bronchial epithelial cells exposed to oxidative stress Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
Effect of genetic polymorphisms of some cytokines and xenobiotic-metabolizing enzymes on the lung function in patients with COPD Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
Common variants of the microsomal epoxide hydrolase and glutamate-cysteine ligase in European populations are not associated with susceptibility to COPD Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Cytochrome P450 1A1 polymorphism and severity of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002